The notification includes the positive BioImage validation study results including 6,600 individuals who demonstrated consistency with company’s design objectives for this new test.
AMIPredict is a cardiovascular diagnostic multivariate index assay which simultaneously measures multiple protein biomarkers in patients’ blood and calculates a risk score.
The test aims to improve the identification of individuals at high risk for near-term major cardiovascular events, such as heart attack and stroke.
